商品分类

浏览历史

B20968	羟基红花黄色素A
源叶	分析标准品,HPLC≥98%

英文名：
Hydroxysafflor yellow A

别名：

CAS号：
78281-02-4

分子式：
C₂₇H₃₂O₁₆

分子量：
612.53

MDL：
MFCD08435942

品牌	货号	产品规格	市场价(RMB)	您的折扣价(RMB)	库存（上海）	北京	武汉	南京	数量	计量单位	加入购物车...
源叶	B20968-20mg	分析标准品,HPLC≥98%	￥450.00元	￥450.00元	>10	1	3	3		EA	加入购物车

大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》，到货后将短信提示。
提交

产品介绍

参考文献(81篇)

质检证书(COA)

摩尔浓度计算器

相关产品

熔点： 184-186 °C

沸点： 1015.8±65.0 °C(Predicted)

外观：黄色粉末

溶解性： DMSO : ≥ 34 mg/mL (55.51 mM)；H2O : 33.33 mg/mL (54.41 mM; Need ultrasonic)

储存条件： 2-8℃

注意：部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

81. [IF=5.4] Yanqiu Sun et al."Network pharmacology integrated with experimental validation revealed the mechanism of Fengshi Gutong Capsule in the treatment of osteoarthritis."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117261

80. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123

79. [IF=3.8] En Hu et al."Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury."PHARMACEUTICAL BIOLOGY.2023;61(1):1054-1064

78. [IF=5.4] Dandan Feng et al."N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116823

77. [IF=6] Rong-Shuai Hu et al."Comparative study on optimization of NADES extraction process by dual models and antioxidant activity of optimum extraction from Chuanxiong-Honghua."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jul;184:114991

76. [4.46] Jiaxi Chen et al."Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota."TOXICOLOGY AND APPLIED PHARMACOLOGY.2023 May;467:116494

75. [5.195] Zelin Lai et al."Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes."JOURNAL OF ETHNOPHARMACOLOGY.2023 May;308:116268

74. [0] Xiaoqing Song et al."Protective effect of hydroxysafflor yellow A on MSCs against senescence induced by D-galactose."Chinese Herbal Medicines.2022 Dec;:

73. [1.698] Mengjie Xue et al."Illumination on Chemical Compounds from Qufeng Zhitong Capsule and Its Potential Pharmacological Mechanism against Rheumatoid Arthritis Based on UHPLC/Q-Orbitrap-MS Combined with Network Pharmacology Analysis."International Journal of A

72. [6.656] Jiling Feng et al."Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagy."PHYTOMEDICINE.2023 Feb;110:154636

71. [7.425] Zhen Yan et al."Composition of major quinochalcone hydroxysafflor yellow A and anhydrosafflor yellow B is associated with colour of safflower (Carthamus tinctorius) during colour-transition but not with overall antioxidant capacity: a study on 144 cultiva

70. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315

69. [IF=7.419] Yule Wang et al."Discovery of anti-stroke active substances in Guhong injection based on multi-phenotypic screening of zebrafish."BIOMEDICINE & PHARMACOTHERAPY.2022 Nov;155:113744

68. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy.

67. [IF=6.53] Qianqian Chen et al."Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study."Biomed Pharmacother. 2022 Jun;150:112950

66. [IF=3.269] Dan Su et al."Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway."Bioengineered. 2021;12(2):11533-11543

65. [IF=6.529] Ting Shang et al."The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment."Biomed Pharmacother. 2022 Apr;148:112675

64. [IF=5.34] Yule Wang et al."Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke."Phytomedicine. 2022 May;99:154034

63. [IF=0.533] Jinyan Jiang et al."Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology."Trop J Pharm Res. 2020 Nov;19(7):1441-1448

62. [IF=1.902] Rui Yao et al."Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice."Biomed Chromatogr. 2021 Oct;35(10):e5173

61. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21

60. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

59. [IF=3.098] Donglai Zhou et al."Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway."Int J Mol Med. 2019 Aug;44(2):405-416

58. [IF=4.225] Shang Ting et al."Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney."Front Pharmacol. 2020 Jan;0:1416

57. [IF=4.36] Li Lin et al."Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration."J Ethnopharmacol. 2021 Nov;280:114471

56. [IF=4.545] Na Wu et al."Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer."Biomed Pharmacother. 2021 Apr;136:111227

55. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273

54. [IF=5.81] Fangma Yijia et al."Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway."Front Pharmacol. 2021 Sep

53. [IF=7.271] Teng Li et al."Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury."Comput Struct Biotec. 2021 Jan;19:1002

52. [IF=7.514] Xin Tong et al."Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents."Food Chem. 2021 Jun;348:129090

51. [IF=7.514] Liuwei Zhao et al."Safflomin A: A novel chemical marker for Carthamus tinctorius L. (Safflower) monofloral honey."Food Chem. 2022 Jan;366:130584

50. [IF=2.1] Bin Ni et al."Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy."Mol Med Rep. 2018 Oct;18(4):3649-3656

49. [IF=2.173] Wenlu Li et al."Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells."Neurosci Lett. 2013 Aug;549:146

48. [IF=2.233] Zhenzhen Ni et al."Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation endproducts in vitro."Biological & Pharmaceutical Bulletin. 2012 Aug 31

47. [IF=2.547] Jing Zhou et al."Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia."Pharmacology. 2018;102(3-4):154-160

46. [IF=2.896] Lu Wang et al."Rapid assay for testing superoxide anion radical scavenging activities to natural pigments by ultra-high performance liquid chromatography-diode-array detection method."Anal Methods-Uk. 2015 Feb;7(4):1535-1542

45. [IF=3.046] Liwei Dong et al."Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1."Oncotargets Ther. 2015; 8: 3649–3664

44. [IF=3.845] Zhang Xianhua et al."Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds."Front Pharmacol. 2017 Jul;0:452

43. [IF=5.81] Yu Li et al."Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study."Front Pharmacol. 2018 May;0:493

42. [IF=10.618] Yao-Xiong Huang et al."Versatile on-stage microfluidic system for long term cell culture, micromanipulation and time lapse assays."Biosens Bioelectron. 2018 Mar;101:66

41. Zhang, Jing, et al. "Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule." Phytomedicine 77 (2020): 153273.https://doi.org/10.1016/j.phymed.2020.153273

40. Jiang, Jinyan, et al. "Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology." Tropical Journal of Pharmaceutical Research 19.7 (2020): 1441-1448.https://doi.org/10.4314/tjpr.v19i7.16

39. Yu, Lu, et al. "Hydroxysafflor yellow a confers neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways." Cellular and molecular neurobiology (2020): 1-11.

38. Zhou, Donglai, et al. "Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway." International journal of molecular medicine 44.2 (2019): 405-416.https://doi.org/10.3892/ijmm.2019.4230

37. Wu, Na, et al. "Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer." Biomedicine & Pharmacotherapy 136 (2021): 111227.https://doi.org/10.1016/j.biopha.2021.111227

36. 黄楷迪,刘敬霞,牛阳,马学琴,张婷,卜凡淑,任慧,郭盛,钱大玮,段金廒.回药扎里奴思方UPLC指纹图谱结合多成分含量测定的质控方法研究[J].南京中医药大学学报,2021,37(01):77-82.

35. 李燕霞,王琳,姚弘毅.HSYA对骨关节炎大鼠膝关节软骨损伤的修复作用研究[J].局解手术学杂志,2021,30(03):195-199.

34. 谢飞,周美兰.羟基红花黄色素A抑制高糖诱导的小鼠肾足细胞损伤[J].基础医学与临床,2021,41(01):27-32.

33. 支旭然刘洪涛吴茵等. UPLC-MS/MS法同时测定肾康注射液中7个有效成分[J]. 药物分析杂志 2017 037(001):37-42.

32. 李正, 潘万芳, 朱立明,等. 基于物质流分析的丹红注射液制药过程质量控制研究[J]. 天津中医药大学学报, 2015, 34(06):349-352.

31. 支旭然董占军吴茵等. HPLC同时测定肾康注射液中的4种成分[J]. 华西药学杂志 2017(03):297-299.

30. 黄赵刚, 程钢, 汤浩,等. 血必净注射液指纹图谱研究[J]. 中国医院药学杂志, 2018, 038(022):2323-2327.

29. 艾进超何昱杨荣兵等. 丹红注射液中主要有效成分在脑缺血大鼠体内药动学研究[J]. 中草药 2015 46(20):79-84.

28. 刘雪石晓倩吴晏杰等. UPLC法同时测定新安名方脑络欣通中5个活性成分的含量[J]. 贵阳中医学院学报 2020年42卷4期 26-31页 ISTIC 2020.

27. 马梦雪吴士筠李刚等. HPLC法同时测定不同品种红花中4种黄酮类[J]. 中成药 2019 041(011):2694-2700.

26. 方雨晨, 万海同, 虞立,等. 谷红注射液主要有效成分在脑缺血模型大鼠体内的药动学研究[J]. 中国中药杂志, 2018, 043(009):1940-1945.

25. 王亚洲, 杨春旭. 蝎龙酒质量标准研究[J]. 中国实验方剂学杂志, 2012, 18(23):105-108.

24. 王亚洲. 蝎龙接骨散质量标准研究[J]. 黑龙江医药, 2012, 25(6):845-847.

23. 易丽娟, 李雅, 邹苏兰,等. 基于正交试验设计与BP神经网络优化益气活血方水提工艺研究[J]. 中草药, 2019, v.50;No.653(18):50-57.

22. 王亚洲. HPLC法同时测定蝎龙酒中芍药苷羟基红花黄色素A和阿魏酸[J]. 中成药 2012 34(010):1925-1928.

21. 王亚洲杨春旭. HPLC同时测定蝎龙接骨散中羟基红花黄色素A和阿魏酸的含量[J]. 中国实验方剂学杂志 2012 18(22):109-111.

20. 陈俊奎, 万海同, 周惠芬,等. 谷红注射液在脑缺血再灌注大鼠体内药动学与抗氧化作用关联性研究[J]. 中草药, 2016, 47(003):447-453.

19. 施笑晖, 唐映红, 陈建真,等. 谷红注射液中羟基红花黄色素A在大鼠体内的药动学研究[J]. 中成药, 2015, 037(011):2387-2391.

18. 潘璐佳, 万海同, 陈俊奎,等. 谷红注射液中2种成分对脑缺血大鼠氨基酸类神经递质释放的协同作用[J]. 中成药, 2019, 041(004):784-788.

17. 吴鸿,雷震,高水波,张玲霞,代丽萍.羟基红花黄色素A通过抑制微小RNA-1表达对H9c2心肌细胞氧化损伤的保护作用[J].北京中医药大学学报,2018,41(08):636-641.

16. 万甜,吴敏瑞,齐振熙.羟基红花黄色素A对激素诱导骨髓间充质干细胞成骨分化的影响[J].中国骨伤,2014,27(03):224-228.

15. 齐振熙, 吴敏瑞, 万甜,等. 羟基红花黄色素A对激素诱导骨髓间充质干细胞ERK1/2的干预作用[J]. 康复学报, 2014, 24(002):13-16.

14. 侯兆阳, 陈哲, 魏家森. 羟基红花黄色素A对急性脊髓损伤模型大鼠神经细胞凋亡的影响[J]. 浙江中西医结合杂志, 2014, 000(009):753-756.

13. 齐振熙,万甜,吴敏瑞,张占勇,仲卫红,于涛.羟基红花黄色素A不同给药方式对激素性股骨头缺血坏死模兔ERK1/2、JNK和p38蛋白表达的影响[J].中华中医药杂志,2014,29(09):2927-2930.

12. 樊启猛, 刘润南, 贺鹏,等. 经典名方单味药材群体指纹图谱信息熵及一次投料量研究[J]. 时珍国医国药, 2020年31卷4期, 975-979页, PKU CSCD CA, 2020.

11. 万甜,吴敏瑞,齐振熙.红花提取物对激素性股骨头缺血坏死兔股骨头组织ERK、JNK和P38蛋白表达的影响[J].中医杂志,2013,54(23):2039-2042.

10. 杜红芳, 耿魁魁, 李冬梅,等. 注射用红花黄色素与6种输液配伍的稳定性[J]. 中成药, 2014, 036(008):1635-1640.

9. 特日格乐, 韩晓静, 宝乐尔,等. 正交试验优选蒙药红花最佳醇提工艺[J]. 智慧健康, 2020, 006(007):47-48.

8. 李海英, 贺鹏, 樊启猛,等. 桃红四物汤HPLC指纹图谱的总量统计矩及一次稳态投料量分析. 中国实验方剂学杂志.

7. ]贺智勇,邹弢,罗田,李婉蓉,杨佳佳,刘学,肖婷,周雪,吴林菁,刘文,沈祥春,陶玲.基于薄荷油为油相的红花提取物自微乳凝胶递送系统制备研究[J].中草药,2020,51(11):2922-2928.

6. 杜辉马永强李春阳等. 响应面法优化复合酶提取红花黄色素工艺[J]. 南方农业学报 2015 46(004):657-663.

5. 范红晶虞立金伟锋李敏周静李晓红张宇燕.原儿茶醛与羟基红花黄色素A单用与合用在高脂血症大鼠体内的药动学-药效学相关性研究[J].中国中药杂志 2017 42(13):2564-2570.

4. 朱振洪黄小飞王玉周郡潘利峰万海同.丹红注射液与羟基红花黄色素A对大鼠脑缺血再灌注后IL-1β、TNF-α和Caspase-3 mRNA表达的影响[J].中华中医药杂志 2016 31(04):1390-1393.

3. 李宵吴茵支旭然等. UPLC-MS/MS同时测定谷红注射液中7种有效成分[J]. 中国实验方剂学杂志 2017(21):64-69.

2. 徐森玲万海同金湛等. PHPLC法同时分离纯化红花中2种成分[J]. 中成药 2017 39(002):436-439.

1. 陈娟周晔陈伟华等. ICU超剂量谷红注射液成品输液的合理性考察[J]. 临床合理用药杂志 2018 11(31):18-21.